MedTrace Logo

Plasma Exchange for Renal Vasculitis

NCT01408836 · Status: TERMINATED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2011-08-03

No results posted yet for this study

Summary

The purpose of this study is to test whether additional therapy with plasma exchange improves the chances of kidney recovery in severe kidney vasculitis.

Conditions

  • Wegener's Granulomatosis
  • Microscopic Polyangiitis

Interventions

PROCEDURE

Plasma exchange

Plasma exchange

DRUG

Intravenous methyl prednisolone

Intravenous methyl prednisolone

DRUG

Methyl prednisolone

methyl prednisolone

Sponsors & Collaborators

  • University Hospital Birmingham

    collaborator OTHER

  • Imperial College London

    collaborator OTHER

  • London North West Healthcare NHS Trust

    collaborator OTHER

  • University Hospitals, Leicester

    collaborator OTHER

  • Lund University Hospital

    collaborator OTHER

  • University Medical Center Groningen

    collaborator OTHER

  • Fundacio Clinic Barcelona

    collaborator OTHER

  • University of Helsinki

    collaborator OTHER

  • Cambridge University Hospitals NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Niels Rasmussen, MD · Righospitalet, Copenhagen, Denmark

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1995-03-31
Primary Completion
2003-06-30
Completion
2003-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01408836 on ClinicalTrials.gov